NASDAQ:GRTX

Galera Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy GRTX

*Your capital is at risk

$0.100

-0.0010 (-0.99%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

GRTX Prediction Chart

GRTX Predictions History

Latest community submissions for GRTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	May 4, 2023	$3.08 -2.37%	$3.06	V	99.50%	4
PredictionBot.Warren Pro	May 4, 2023	$3.10 -1.48%	$3.06	V	98.58%	2
fosteralijah415.355075	May 4, 2023	Bullish	$3.06	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GRTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GALERA THERAPEUTICS, INC.

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by